[ad_1]
According to Kirill Dmitriev the results of the third clinical phase of the Russian vaccine may be published in a major international medical journal next week, which, by the way, has been lacking so far by many medical experts, as the Russian population began to be massively vaccinated with the product at home without the knowledge or publication of the data.
According to the Interfax build anyway Together with Hungary, the pharmaceutical authorities of a total of 11 countries have so far approved the use of Sputnik V, which according to Moscow is 91.4% effective against the coronavirus. Both Pfizer / BioNtech and Moderna claim to be 95% efficient using mRNA-based technology. The great advantage of vector-based Sputnik V is that it can be transported or stored at a simple refrigerator temperature.
According to the Russian Minister of Health, the TASS news agency reported that Even in Russia, only 6.5 million doses could be produced from the vaccine. (One dose consists of a first dose and a second “confirmatory” dose to be paid 21 days later) and 5.2 million will be shipped to Russian regions shortly.
This also suggests that, at the moment, even the Russians do not have Sputnik V available to them in large numbers, although it is understandable that they want to provide it to their own population first. All this points to As of February, only a small amount (not yet quantified) of doses can reach Hungary, that even the NNK should examine as soon as possible, in addition to the OGYÉI permit, it also issues the permit so that people can be vaccinated with it at home.
Cover Image Source: Getty Images
[ad_2]
